23 Nov

Change of Directors Interest Notice X2

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Imagion Biosystems Limited ABN 42 616 305 027 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Robert Proulx Date of last notice 22 October 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 17 November 2021 Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 No. of securities held prior to change 1) 5,987,000 Ordinary Shares 2) 5,000,000 Performance Rights 3) 176,250 Listed IBXO options (exercisable at $0.05, expiring on 26 November 2021) 4) 282,000 Listed IBXOA options (exercisable at $0.03, expiring on 28 April 2023) 5) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2021, expiring 1 May 2026) 6) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2022, expiring 1 May 2027) 7) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2023, expiring 1 May 2028) Class Fully Paid Ordinary Shares Number acquired 1) 176,250 Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation 1) $8,812.50 No. of securities held after change 1) 6,163,250 Ordinary Shares 2) 5,000,000 Performance Rights 3) Nil Listed IBXO options (exercisable at $0.05, expiring on 26 November 2021) 4) 282,000 Listed IBXOA options (exercisable at $0.03, expiring on 28 April 2023) 5) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2021, expiring 1 May 2026) 6) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2022, expiring 1 May 2027) 7) 2,000,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2023, expiring 1 May 2028) Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back Exercise of Listed IBXO Options Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Imagion Biosystems Limited ABN 42 616 305 027 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director David Ludvigson Date of last notice 11 August 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 19 November 2021 No. of securities held prior to change 1) 470,000 Ordinary Shares 2) 75,000 Listed IBXO options (exercisable at $0.05, expiring on 26 November 2021) 3) 120,000 Listed IBXOA options (exercisable at $0.03, expiring on 28 April 2023) 4) 250,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2021, expiring 1 May 2026) 5) 250,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2022, expiring 1 May 2027) Class Fully Paid Ordinary Shares Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Number acquired 1) 75,000 Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation 1) $3,750 No. of securities held after change 1) 545,000 Ordinary Shares 2) Nil Listed IBXO options (exercisable at $0.05, expiring on 26 November 2021) 3) 120,000 Listed IBXOA options (exercisable at $0.03, expiring on 28 April 2023) 4) 250,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2021, expiring 1 May 2026) 5) 250,000 Unlisted Performance Options (exercisable at $0.028, vesting on 1 May 2022, expiring 1 May 2027) Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back Exercise of Listed IBXO Options Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Imagion Biosystems Limited (ASX:IBX) when you join Listcorp.